Inhibition of angiogenesis and tumor progression of MK-0429, an integrin αvβ3 antagonist, on oral squamous cell carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1335
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Inhibition of angiogenesis and tumor progression of MK-0429, an integrin αvβ3 antagonist, on oral squamous cell carcinoma ; day:17 ; month:6 ; year:2022 ; pages:1-12
Journal of cancer research and clinical oncology ; (17.6.2022), 1-12
- Urheber
-
Nakagawa, Takayuki
Ohta, Kouji
Naruse, Takako
Sakuma, Miyuki
Fukada, Syohei
Yamakado, Nao
Akagi, Misaki
Sasaki, Kazuki
Niwata, Chieko
Ono, Shigehiro
Aikawa, Tomonao
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00432-022-04100-3
- URN
-
urn:nbn:de:101:1-2022081622233292424978
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nakagawa, Takayuki
- Ohta, Kouji
- Naruse, Takako
- Sakuma, Miyuki
- Fukada, Syohei
- Yamakado, Nao
- Akagi, Misaki
- Sasaki, Kazuki
- Niwata, Chieko
- Ono, Shigehiro
- Aikawa, Tomonao
- SpringerLink (Online service)
Ähnliche Objekte (12)
Superactivation of integrin αvβ3 by low antagonist concentrations
Integrin αVβ3 antagonist-c(RGDyk) peptide attenuates the progression of ossification of the posterior longitudinal ligament by inhibiting osteogenesis and angiogenesis
αVβ3 Integrin regulates astrocyte reactivity
Targeting the Tie2–αvβ3 integrin axis with bi-specific reagents for the inhibition of angiogenesis
Evaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCit
A selective cyclic integrin antagonist blocks the integrin receptors αvβ3 and αvβ5and inhibits retinal pigment epithelium cell attachment, migration and invasion
Humanes ADAM15 als potentieller natürlicher Integrin-αvβ3-Antagonist [Integrin-alpha-v-beta-3-Antagonist] : Einfluß der ADAM15-Expression auf Migration und Zell-Zell-Adhäsion von humanen Ovarialkarzinomzellen
![αvβ3-Integrin-Inhibitoren [Alpha-v-beta-3-Integrin-Inhibitoren] durch räumliches Screening](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
αvβ3-Integrin-Inhibitoren [Alpha-v-beta-3-Integrin-Inhibitoren] durch räumliches Screening
αvβ3 integrin expression increases elasticity in human melanoma cells
Vedolizumab : ein neuer darmselektiver Integrin-Antagonist
Cyr61 promotes Schwann cell proliferation and migration via αvβ3 integrin
There is a world beyond αvβ3-integrin: Multimeric ligands for imaging of the integrin subtypes αvβ6, αvβ8, αvβ3, and α5β1 by positron emission tomography
Superactivation of integrin αvβ3 by low antagonist concentrations
Integrin αVβ3 antagonist-c(RGDyk) peptide attenuates the progression of ossification of the posterior longitudinal ligament by inhibiting osteogenesis and angiogenesis
αVβ3 Integrin regulates astrocyte reactivity
Targeting the Tie2–αvβ3 integrin axis with bi-specific reagents for the inhibition of angiogenesis
Evaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCit
A selective cyclic integrin antagonist blocks the integrin receptors αvβ3 and αvβ5and inhibits retinal pigment epithelium cell attachment, migration and invasion
Humanes ADAM15 als potentieller natürlicher Integrin-αvβ3-Antagonist [Integrin-alpha-v-beta-3-Antagonist] : Einfluß der ADAM15-Expression auf Migration und Zell-Zell-Adhäsion von humanen Ovarialkarzinomzellen
αvβ3-Integrin-Inhibitoren [Alpha-v-beta-3-Integrin-Inhibitoren] durch räumliches Screening
αvβ3 integrin expression increases elasticity in human melanoma cells
Vedolizumab : ein neuer darmselektiver Integrin-Antagonist
Cyr61 promotes Schwann cell proliferation and migration via αvβ3 integrin
There is a world beyond αvβ3-integrin: Multimeric ligands for imaging of the integrin subtypes αvβ6, αvβ8, αvβ3, and α5β1 by positron emission tomography
Superactivation of integrin αvβ3 by low antagonist concentrations
Integrin αVβ3 antagonist-c(RGDyk) peptide attenuates the progression of ossification of the posterior longitudinal ligament by inhibiting osteogenesis and angiogenesis
αVβ3 Integrin regulates astrocyte reactivity
Targeting the Tie2–αvβ3 integrin axis with bi-specific reagents for the inhibition of angiogenesis
Evaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCit
A selective cyclic integrin antagonist blocks the integrin receptors αvβ3 and αvβ5and inhibits retinal pigment epithelium cell attachment, migration and invasion
Humanes ADAM15 als potentieller natürlicher Integrin-αvβ3-Antagonist [Integrin-alpha-v-beta-3-Antagonist] : Einfluß der ADAM15-Expression auf Migration und Zell-Zell-Adhäsion von humanen Ovarialkarzinomzellen
αvβ3-Integrin-Inhibitoren [Alpha-v-beta-3-Integrin-Inhibitoren] durch räumliches Screening
αvβ3 integrin expression increases elasticity in human melanoma cells
Vedolizumab : ein neuer darmselektiver Integrin-Antagonist
Cyr61 promotes Schwann cell proliferation and migration via αvβ3 integrin